CATALANO, Myriam
 Distribuzione geografica
Continente #
NA - Nord America 1.598
EU - Europa 814
AS - Asia 142
AF - Africa 16
SA - Sud America 12
OC - Oceania 1
Totale 2.583
Nazione #
US - Stati Uniti d'America 1.586
IT - Italia 559
SE - Svezia 104
IN - India 71
CN - Cina 65
DE - Germania 33
FI - Finlandia 27
UA - Ucraina 27
FR - Francia 16
TG - Togo 15
CA - Canada 12
GB - Regno Unito 12
RO - Romania 10
AR - Argentina 6
BE - Belgio 5
BG - Bulgaria 4
BR - Brasile 4
IE - Irlanda 4
IR - Iran 4
NL - Olanda 4
CH - Svizzera 3
CL - Cile 2
AT - Austria 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HR - Croazia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
Totale 2.583
Città #
Fairfield 290
Rome 217
Chandler 131
Woodbridge 126
Ashburn 105
Seattle 105
Houston 102
Cambridge 90
Wilmington 79
Beijing 44
Princeton 41
San Paolo di Civitate 35
Ann Arbor 32
Lawrence 31
Plano 31
San Diego 29
Boston 23
Lomé 15
Fremont 14
Milan 13
Millbury 12
Andover 11
Des Moines 10
Dearborn 8
Phoenix 8
Bremen 7
Jacksonville 7
Verona 7
Washington 7
Dallas 6
Federal 6
Ottawa 6
Perugia 6
Toronto 6
Norwalk 5
Piemonte 5
Torino 5
Bologna 4
Brussels 4
Dublin 4
Hefei 4
Leawood 4
Napoli 4
Rio De Janeiro 4
Sofia 4
Boardman 3
Fasano 3
Genova 3
Heidelberg 3
Monza 3
Nanjing 3
Pessac-sur-Dordogne 3
Poli 3
Redwood City 3
Reggio Calabria 3
Southend 3
Venezia 3
Atlanta 2
Catania 2
Cattolica 2
Giugliano In Campania 2
Hebei 2
Kunming 2
Laurel 2
London 2
Minturno 2
Nanchang 2
New Delhi 2
Nürnberg 2
Oxford 2
Palermo 2
Paris 2
Prilly 2
Romainville 2
San Mateo 2
Trento 2
Trieste 2
Tübingen 2
Viano 2
Zanjan 2
Acerra 1
Alghero 1
Amsterdam 1
Asti 1
Auckland 1
Bergamo 1
Bern 1
Biella 1
Brescia 1
Bucharest 1
Cagliari 1
Capannori 1
Caserta 1
Castel Gandolfo 1
Castelleone 1
Castelnuovo Di Porto 1
Catanzaro 1
Certaldo 1
Chaoyang 1
Chengdu 1
Totale 1.809
Nome #
La Fractalchina, farmaco neuroprotettore contro la morte cellulare dovuta a processi eccitotossici, segnatamente ischemia cerebrale e lesioni midollari 316
Microglia-derived microvesicles affect microglia phenotype in glioma 111
KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages 99
Kv1.3 activity perturbs the homeostatic properties of astrocytes in glioma 97
Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells 96
CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes 89
Defective microglial development in the hippocampus of Cx3cr1 deficient mice 83
Fractalkine in the nervous system: neuroprotective or neurotoxic molecule? 83
Chiral indolylarylsulfone non-nucleoside reverse transcriptase inhibitors as new potent and broad spectrum anti-HIV-1 agents 83
Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. 81
Muscle Damage in Dystrophic mdx Mice Is Influenced by the Activity of Ca2+-Activated KCa3.1 Channels 79
Premature changes in neuronal excitability account for hippocampal network impairment and autistic-like behavior in neonatal BTBR T+tf/J mice 78
Functional roles of the Ca2+-activated K+ channel, KCa3.1, in brain tumors 78
KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment 77
Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation 74
Riluzole blocks human muscle acetylcholine receptors 71
CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity 70
Activity-Dependent Regulation of Synaptic AMPA Receptor Composition and Abundance by b3 Integrins 65
Functional properties of neurons derived from fetal mouseneurospheres are compatible with those of neuronal precursors in vivo. 65
Fluoxetine prevents acetylcholine-induced excitotoxicity blocking human endplate acetylcholine receptor. 61
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains 61
Evidence for a role of glycosphingolipids in CXCR4-dependent cell migration 60
Chemokine CXCL8 modulates GluR1 phosphorylation 60
Microglia-Derived Small Extracellular Vesicles Reduce Glioma Growth by Modifying Tumor Cell Metabolism and Enhancing Glutamate Clearance through miR-124 55
Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. 54
Transient increase in neuronal chloride concentration by neuroactive amino acids released from glioma cells 52
KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo 52
Autophagy induction impairs Wnt/β-catenin signalling through β-catenin relocalisation in glioblastoma cells 51
Microglial expression of GAT-1 in the cerebral cortex 47
Ligand-independent CXCR2 dimerization 44
Role of Infiltrating Microglia/Macrophages in Glioma 44
Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons 43
Fractalkine/CX3CL1 modulates GABAA currents in human temporal lobe epilepsy 35
Trasmembrane chemokines CX3CL1 and CXCL16 drive interplay between neurons, microglia and astrocytes to counteract pMCAO and excitotoxic neuronal death 35
Using fractalkine to produce a drug neuroprotective against cell death 34
Astrocytes-Derived Small Extracellular Vesicles Hinder Glioma Growth 33
Cys residues are critical for chemokine receptor CXCR2 functional properties. 28
The chemokine CX3CL1 reduces migration and increases adhesion of neurons with mechanisms dependnet on the b1 integrin subunit. 24
Microglial Extracellular Vesicles as Modulators of Brain Microenvironment in Glioma 15
Early developmental changes of muscle acetylcholine receptors are little influenced by dystrophin absence in mdx mouse 8
Lipopolysaccharide augments microglial GABA uptake by increasing GABA transporter‐1 trafficking and bestrophin‐1 expression 6
Editorial: Brain Tumors and Neuroinflammation 5
Adult IDH wild-type glioblastoma ultrastructural investigation suggests a possible correlation between morphological biomarkers and Ki-67 index 4
CALCIUM-ACTIVATED POTASSIUM CHANNELS: A POSSIBLE TARGET FOR THE PHARMACOLOGICAL TREATMENT OF GLIOBLASTOMA 3
Totale 2.709
Categoria #
all - tutte 5.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 423
selected - selezionate 0
volume - volumi 0
Totale 5.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019345 0 0 26 9 12 3 5 5 8 62 127 88
2019/2020598 70 23 5 29 63 68 76 60 70 72 33 29
2020/2021288 21 25 27 14 18 21 12 22 35 68 17 8
2021/2022491 3 21 52 35 52 7 11 51 29 37 113 80
2022/2023577 94 110 45 36 55 61 27 44 50 9 30 16
2023/2024102 31 37 34 0 0 0 0 0 0 0 0 0
Totale 2.709